Related Experiment Video
Updated: May 11, 2025
Analysis of Cell Suspensions Isolated from Solid Tissues by Spectral Flow Cytometry
Published on: May 5, 2017
Elucidating Immune Cell Changes in Celiac Disease: Revealing New Insights from Spectral Flow Cytometry
Sara Gómez-Aguililla1, Sergio Farrais2,3, Carla Senosiain4
1Laboratorio de Investigación en Genética de Enfermedades Complejas, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.
Insights
Celiac disease patients show altered immune cell profiles, including fewer memory B cells. A gluten challenge revealed specific T cell responses, with CCR9 aiding identification for potential diagnostic improvements.
Area of Science:
- Immunology
- Gastroenterology
- Cell Biology
Background:
- Celiac disease (CD) is an immune-mediated enteropathy triggered by gluten.
- While the small intestine is primarily affected, peripheral blood cell changes are noted in CD.
- Understanding these blood cell alterations is crucial for diagnosis and monitoring.
Purpose of the Study:
- To investigate immunological cell patterns in treated celiac disease patients.
- To analyze blood cell responses following a short-term gluten challenge (GC).
- To evaluate the utility of spectral flow cytometry and specific markers in identifying gluten-responsive cells.
Main Methods:
- Blood samples from 10 treated CD patients and 8 healthy controls were analyzed.
- Samples were collected at baseline and 6 days after initiating a 3-day GC.
- Spectral flow cytometry with a 34-marker panel was employed for cell analysis.
Main Results:
- CD patients had a lower proportion of memory B cells compared to controls, persisting after GC.
- Activated gut-homing T lymphocytes (CD4+, CD8+, TCRγδ+) were observed post-GC.
- CD8+ T cells were most identifiable, and the CCR9 marker enhanced gluten-responsive T cell selection.
Conclusions:
- Treated CD patients exhibit distinct peripheral blood immune cell profiles.
- A short gluten challenge elicits specific T cell responses in CD patients.
- Spectral flow cytometry and CCR9 marker show promise for improved diagnostic accuracy in celiac disease.
Abstract:
Celiac disease (CD) is an immune-mediated enteropathy of the small intestine triggered by gluten ingestion. Although the small bowel is the main organ affected, peripheral blood cell alterations have also been described in CD. We aimed to investigate immunological cell patterns in the blood of treated CD patients and in response to a 3-day gluten challenge (GC). Blood samples were collected from 10 patients with CD and 8 healthy controls on a gluten-free diet at baseline and 6 days after initiating the GC. All the samples were analyzed by spectral flow cytometry using a 34-marker panel. We found that patients with CD displayed a lower proportion of memory B cells compared to healthy controls, both at baseline and post-GC. Additionally, we observed the previously reported activated gut-homing CD4+, CD8+, and TCRγδ+ T lymphocytes on day 6 post-GC, and found the CD8+ subpopulation to be the most readily identifiable by flow cytometry. Importantly, the CCR9 marker proved effective in enhancing the selection of these gluten-responsive T cells, offering the potential for increased diagnostic accuracy. Spectral flow cytometry involves a complex data analysis, but it offers valuable insights into previously unexplored immunological responses and enables in-depth cell characterization.
